Medtronic MiniMed, Inc. v. Nova Biomedical Corp.
In a matter involving multiple causes of action centering on the manufacture of blood glucose meters, a California jury held that Analysis Group client Nova Biomedical Corporation had not engaged in misappropriation of trade secrets, breach of contract, tortious interference, or conversion as alleged by plaintiff Medtronic MiniMed, Inc. Medtronic had sought more than $30 million in damages, a permanent injunction, a finding of willful misappropriation, and punitive damages from Nova.
Nova counsel Ropes & Gray retained Analysis Group to assess damages related to Medtronic's allegations. Affiliate Laura Stamm provided deposition and trial testimony -- including rebuttal testimony -- on the appropriateness of plaintiff's expert's damages methodology, lost profits, unjust enrichment, and apportionment. Vice President Lindsay Greenbaum supported Ms. Stamm.
After five days of deliberation, the U.S. District Court for the Central District of California jury awarded what Ropes & Gray lead trial counsel Bradford J. Badke termed "a complete victory" to Nova.